BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 11180222)

  • 1. Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations.
    Amir RE; Zoghbi HY
    Am J Med Genet; 2000; 97(2):147-52. PubMed ID: 11180222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rett syndrome: the complex nature of a monogenic disease.
    Renieri A; Meloni I; Longo I; Ariani F; Mari F; Pescucci C; Cambi F
    J Mol Med (Berl); 2003 Jun; 81(6):346-54. PubMed ID: 12750821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots.
    Wan M; Lee SS; Zhang X; Houwink-Manville I; Song HR; Amir RE; Budden S; Naidu S; Pereira JL; Lo IF; Zoghbi HY; Schanen NC; Francke U
    Am J Hum Genet; 1999 Dec; 65(6):1520-9. PubMed ID: 10577905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry.
    LaSalle JM; Goldstine J; Balmer D; Greco CM
    Hum Mol Genet; 2001 Aug; 10(17):1729-40. PubMed ID: 11532982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mutation spectrum and genotype-phenotype correlation of MECP2 in patients with Rett syndrome].
    Kondo I; Yamagata H
    No To Hattatsu; 2002 May; 34(3):219-23. PubMed ID: 12030010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MeCP2 mutations in children with and without the phenotype of Rett syndrome.
    Hoffbuhr K; Devaney JM; LaFleur B; Sirianni N; Scacheri C; Giron J; Schuette J; Innis J; Marino M; Philippart M; Narayanan V; Umansky R; Kronn D; Hoffman EP; Naidu S
    Neurology; 2001 Jun; 56(11):1486-95. PubMed ID: 11402105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phenotypic consequences of MECP2 mutations extend beyond Rett syndrome.
    Hammer S; Dorrani N; Dragich J; Kudo S; Schanen C
    Ment Retard Dev Disabil Res Rev; 2002; 8(2):94-8. PubMed ID: 12112734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the gene encoding methyl-CpG-binding protein 2 cause Rett syndrome.
    Van den Veyver IB; Zoghbi HY
    Brain Dev; 2001 Dec; 23 Suppl 1():S147-51. PubMed ID: 11738862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genotype-phenotype correlations in Rett syndrome: the study of Russian cohort of patients].
    Vorsanova SG; Ulas VIu; Iurov IuB; Giovanucci-Uzielli ML; Demidova IA; Gianti L; Villard L; Iurov IIu; Beresheva AK; Novikov PV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(10):23-9. PubMed ID: 12449561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype.
    Hoffbuhr KC; Moses LM; Jerdonek MA; Naidu S; Hoffman EP
    Ment Retard Dev Disabil Res Rev; 2002; 8(2):99-105. PubMed ID: 12112735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.
    Amir RE; Van den Veyver IB; Wan M; Tran CQ; Francke U; Zoghbi HY
    Nat Genet; 1999 Oct; 23(2):185-8. PubMed ID: 10508514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations.
    Shahbazian MD; Zoghbi HY
    Curr Opin Neurol; 2001 Apr; 14(2):171-6. PubMed ID: 11262731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients.
    Huppke P; Laccone F; Krämer N; Engel W; Hanefeld F
    Hum Mol Genet; 2000 May; 9(9):1369-75. PubMed ID: 10814718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classic Rett syndrome in a boy with R133C mutation of MECP2.
    Masuyama T; Matsuo M; Jing JJ; Tabara Y; Kitsuki K; Yamagata H; Kan Y; Miki T; Ishii K; Kondo I
    Brain Dev; 2005 Sep; 27(6):439-42. PubMed ID: 16122633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MECP2 mutations in Czech patients with Rett syndrome and Rett-like phenotypes: novel mutations, genotype-phenotype correlations and validation of high-resolution melting analysis for mutation scanning.
    Zahorakova D; Lelkova P; Gregor V; Magner M; Zeman J; Martasek P
    J Hum Genet; 2016 Jul; 61(7):617-25. PubMed ID: 26984561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms.
    Fukuda T; Yamashita Y; Nagamitsu S; Miyamoto K; Jin JJ; Ohmori I; Ohtsuka Y; Kuwajima K; Endo S; Iwai T; Yamagata H; Tabara Y; Miki T; Matsuishi T; Kondo I
    Brain Dev; 2005 Apr; 27(3):211-7. PubMed ID: 15737703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of MECP2 in Japanese patients with atypical Rett syndrome.
    Inui K; Akagi M; Ono J; Tsukamoto H; Shimono K; Mano T; Imai K; Yamada M; Muramatsu T; Sakai N; Okada S
    Brain Dev; 2001 Jul; 23(4):212-5. PubMed ID: 11376998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome.
    Buschdorf JP; Strätling WH
    J Mol Med (Berl); 2004 Feb; 82(2):135-43. PubMed ID: 14618241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental disorders.
    Psoni S; Sofocleous C; Traeger-Synodinos J; Kitsiou-Tzeli S; Kanavakis E; Fryssira-Kanioura H
    Brain Dev; 2012 Jun; 34(6):487-95. PubMed ID: 21982064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of MECP2 mutations in the expression patterns of Rett syndrome patients.
    Ballestar E; Ropero S; Alaminos M; Armstrong J; Setien F; Agrelo R; Fraga MF; Herranz M; Avila S; Pineda M; Monros E; Esteller M
    Hum Genet; 2005 Jan; 116(1-2):91-104. PubMed ID: 15549394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.